Key result
Low adherence to anticoagulant therapy in patients with atrial fibrillation was associated with higher situational anxiety and depression.
Why the study?
The study was conducted to determine the potential impact of anxiety and depression disorders on adherence to anticoagulant therapy among patients with atrial fibrillation.
Do anxiety and depression disorders impact adherence to anticoagulant therapy in patients with atrial fibrillation?
Cross-Sectional (n=117)
Do anxiety and depression disorders impact adherence to anticoagulant therapy in patients with atrial fibrillation?
Anxiety and depression are significantly associated with lower adherence to anticoagulant therapy in patients with atrial fibrillation, highlighting the potential value of psychological screening.
Answers are grounded in this paper and cite their sources.
May support anxiety/depression screening in AF anticoagulant care; leaves open causality and need for prospective trials.
Aim. To determine the possible impact of anxiety and depression disorders on the adherence of patients with atrial fibrillation (AF) to anticoagulant the rapy. Material and methods. The study included outpatients with AF of any type. After signing the informed consent, patients filled out questionnaires and scales that determined the level of anxiety and personal predisposition (MMAS-8, MMAS-4, SF-36, SHAI, STAI, HADS, NEO-FFI). Results. A total of 117 outpatients treated for AF were included. The mean age of patients was 74±5 years (men, 38%). Based on MMAS-4 and MMAS-8 results, adherent and non-adherent cohorts of patients were formed. Low adherence group had significantly higher situational anxiety according to STAI (45,9±9,9 vs 41,1±10,7, p=0,045) and depression according to HADS (7,9±3,6 vs 5,9±3,5, p=0,018). SF 36 showed that non-adherent patients had a lower general health (41,6±12,9 vs 52,2±20,0, p=0,01). Five-factor model revealed an association between low compliance and low extraversion (21,3±6,6 vs 26,4±7,2, p=0,002). Pharmacokinetic data on blood concentrations of anticoagulants or its metabolites at the second visit were available in 76 (67%) patients. Assessment of pharmacokinetic and compliance data revealed a moderate direct correlation (Matthews correlation coefficient (MCC), 0,345) and a weak direct correlation with the MMAS-8 (MCC, 0,177). The difference in MMAS-4 and MMAS-8 scores between high and low pharmacokinetic adherence groups was significant on both scales (p=0,011 and 0,015, respectively). Conclusion. The rationale for widespread introduction of standardized questionnaires and scales (MMAS 4, MMAS 8, STAI, HADS, SF 36, Big 5) was shown in order to early identify patients with low adherence to treatment. The results highlight the need for further study of the contribution of psychiatric disorders to low compliance to anticoagulant therapy.
No takes yet. Share an insight, caveat, or question.
Bogdanova et al. (2022) conducted a cross-sectional in atrial fibrillation (n=117). Low adherence to anticoagulant therapy vs. High adherence was evaluated on Situational anxiety score (STAI) (p=0.045). Low adherence to anticoagulant therapy in patients with atrial fibrillation was associated with higher situational anxiety and depression.
Synapse has enriched 10 related papers. Consider them for comparative context: